Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 1/1997

01-01-1997 | Review Article

Cancer Chemotherapy in Older Adults

A Tolerability Perspective

Authors: Dr Gretchen G. Kimmick, Ronald Fleming, Hyman B. Muss, Lodovico Balducci

Published in: Drugs & Aging | Issue 1/1997

Login to get access
Metadata
Title
Cancer Chemotherapy in Older Adults
A Tolerability Perspective
Authors
Dr Gretchen G. Kimmick
Ronald Fleming
Hyman B. Muss
Lodovico Balducci
Publication date
01-01-1997
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 1/1997
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-199710010-00004

Other articles of this Issue 1/1997

Drugs & Aging 1/1997 Go to the issue

Leading Article

Screening for Glaucoma

Review Article

The Treatment of Sundowning

Review Article

Androgen Receptor Gene Mutations in Prostate Cancer

Review Article

The Cost of Depression in the Elderly

Review Article

Advances in the Management of Digoxin Toxicity in the Older Patient
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits